Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
批准号:
10217133
负责人:
Andrew Patterson
金额:
$34.56万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2023-07-31
关键词:
16S ribosomal RNA sequencingAddressAdultAlbuminsAroclor 1254Aryl Hydrocarbon ReceptorAutomobile DrivingBioinformaticsBiologyCeramidesConsultDataDependenceDevelopmentDietDioxinsDisease OutcomeDoseElectrophoretic Mobility Shift AssayEnvironmental PollutantsEnvironmental PollutionExperimental DesignsExposure toFatty LiverFutureGenesGenomicsGerm-FreeGnotobioticHepaticHumanInflammationInflammatoryIntestinesKnock-outLCN2 geneLigandsLinkLiverMeasurementMediatingMetabolicMetabolic DiseasesMetagenomicsMolecular ToxicologyMusObesityPathogenesisPathway interactionsPolychlorinated BiphenylsPopulationPredispositionProductionPublicationsReceptor ActivationRepressionResearchResearch PersonnelRoleSequence AnalysisSpecificityStructureTechniquesTetrachlorodibenzodioxinTimeTissuesToxicologyWeaningaryl hydrocarbon receptor ligandbacterial communitychromatin immunoprecipitationconditional knockoutcytokinedietaryexperimental studyflexibilitygut microbiomegut microbiotahost microbiomeinnovationinsightinterestlipid biosynthesisliver developmentmetabolic phenotypemetabolomicsmicrobiomemid-career facultymouse modelnon-alcoholic fatty liver diseasenovelprogramsrRNA Genesresponsesystemic inflammatory responsevillin
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
The aryl hydrocarbon receptor (AHR) modulates the host-microbiome metabolic axis. There are strong links
between the gut microbiota and the development and/or exacerbation of nonalcoholic fatty liver disease
(NAFLD), all of which are modulated by activation or repression of the AHR. A mechanistic connection
between AHR activation, changes in gut microbiota composition/function, and NAFLD development has not
been established. Further, the concept that environmental pollutant-mediated disruption and/or modulation of
the AHR-gut microbiota metabolic axis leads to the development of NAFLD has not been addressed. Our
published4-7 and preliminary data with 2,3,7,8-tetrachlorodibenzofuran (TCDF) indicates AHR activation
profoundly alters the gut microbiota in a qualitative and quantitative manner, increases hepatic lipogenesis,
significantly alters hepatic ceramide synthesis through direct AHR activity (a proposed driver of NAFLD), and
increases systemic inflammation. These results have led to the novel central hypothesis: Dietary exposure to
potent environmental AHR ligands leads to functionally significant changes in the gut microbiota that
exacerbate NAFLD in a time- and Ahr-dependent manner.
Through the innovative use of cutting-edge techniques (16S rRNA gene sequencing, metagenomics and
metabolomics) and unique mouse models (tissue specific knockouts of Ahr, gnotobiotic mice, and fecal
transfer experiments), we plan to identify the functional changes imparted to the gut microbiota following
dietary exposure to potent AHR ligands such as TCDF and to evaluate the AHR-dependent role of ceramides
in driving NAFLD pathogenesis and progression. This combination of approaches will allow us to accurately
assess bacterial community dynamics and its interaction with and impact on the host, and whether these
changes result in increased susceptibility to NAFLD. We are particularly interested in how the timing (weaning,
adulthood) of the exposure influences disease outcome. This study will provide new insight into the effects of
exposure on a number of environmentally relevant persistent AHR ligands, such as 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD) and co-planar PCBs (PCB-126) and provide valuable endpoints for future studies in human
populations.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1080/19490976.2020.1848209
发表时间:
2020-11-09
期刊:
Gut microbes
影响因子:
12.2
作者:
[Tian Y, Gui W, Rimal B, Koo I, Smith PB, Nichols RG, Cai J, Liu Q, Patterson AD]
通讯作者:
Patterson AD
DOI:
10.3390/metabo12100894
发表时间:
2022-09-23
期刊:
Metabolites
影响因子:
4.1
作者:
[Tian Y, Rimal B, Gui W, Koo I, Smith PB, Yokoyama S, Patterson AD]
通讯作者:
Patterson AD
DOI:
10.1016/j.tox.2020.152365
发表时间:
2020-01
期刊:
Toxicology
影响因子:
4.5
作者:
[Limin Zhang;Bipin Rimal;Robert G. Nichols;Yuan Tian;Philip B. Smith;E. Hatzakis;Shu-ching Chang]
通讯作者:
Limin Zhang;Bipin Rimal;Robert G. Nichols;Yuan Tian;Philip B. Smith;E. Hatzakis;Shu-ching Chang
Environmental Chemical Impact on the Host-Microbiome Interaction
-
批准号:10641509
-
项目类别:
-
资助金额:$93.15万
-
财政年份:2023
-
负责人:Andrew Patterson
-
依托单位:
Integrative Analysis of Metabolic Phenotypes (IAMP) Predoctoral Training Program
-
批准号:10417044
-
项目类别:
-
资助金额:$19.59万
-
财政年份:2020
-
负责人:Andrew Patterson
-
依托单位:
Integrative Analysis of Metabolic Phenotypes (IAMP) Predoctoral Training Program
-
批准号:10626745
-
项目类别:
-
资助金额:$19.72万
-
财政年份:2020
-
负责人:Andrew Patterson
-
依托单位:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
-
批准号:10311068
-
项目类别:
-
资助金额:$64.15万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
-
批准号:10066327
-
项目类别:
-
资助金额:$65.46万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
-
批准号:9906573
-
项目类别:
-
资助金额:$65.46万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
-
批准号:10228735
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
Unique targeting of PPARβ/δ regulation for cancer prevention and therapy
-
批准号:10539245
-
项目类别:
-
资助金额:$64.15万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
-
批准号:10488612
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
-
批准号:10671560
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
R01: FXR and the Gut Microbiome as Modulators of Non-Alcoholic Fatty Liver Disease
-
批准号:10022323
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2019
-
负责人:Andrew Patterson
-
依托单位:
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
-
批准号:9753729
-
项目类别:
-
资助金额:$34.63万
-
财政年份:2017
-
负责人:Andrew Patterson
-
依托单位:
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
-
批准号:9982685
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2017
-
负责人:Andrew Patterson
-
依托单位:
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
-
批准号:9419367
-
项目类别:
-
资助金额:$15.72万
-
财政年份:2017
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8545853
-
项目类别:
-
资助金额:$33.73万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8416524
-
项目类别:
-
资助金额:$47.86万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8914846
-
项目类别:
-
资助金额:$12.25万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8857440
-
项目类别:
-
资助金额:$38.94万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:9066662
-
项目类别:
-
资助金额:$25.78万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
-
批准号:8687654
-
项目类别:
-
资助金额:$40.28万
-
财政年份:2012
-
负责人:Andrew Patterson
-
依托单位:
海外基金